ENVERIC BIOSCIENCES, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, other for the quarter ending 2026-06-30 was $4.41M.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, other for the quarter ending 2026-03-31 was $1.14M.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, other for the quarter ending 2024-03-31 was $1.54M.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, other for fiscal 2024 was $1.54M.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, other for fiscal 2019 was $22.27K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, other for fiscal 2014 was $50.00K, a 50.00% decline from fiscal 2013.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, other for fiscal 2013 was $100.00K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $4.41M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.14M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $1.54M 10-K · filed 2026-03-27 | |
| 2024-03-31 | $1.54M 10-Q · filed 2025-11-14 | |
| 2019-12-31 | $22.27K 10-K · filed 2021-04-01 | |
| 2014-12-31 | $50.00K 10-K · filed 2015-03-31 | |
| 2013-12-31 | $100.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |